Tetraspanin 7 autoantibodies predict progressive decline of beta cell function in individuals with LADA
Conclusions/interpretationTSPAN7A are valid islet autoantibodies for use in East Asian populations with autoimmune diabetes and can discriminate individuals with LADA who have lower beta cell function after disease progression.
Source: Diabetologia - Category: Endocrinology Source Type: research
More News: Autoimmune Disease | Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Study